Gait Speed and Survival in Older Adults, JAMA, vol.305, issue.1 ,
DOI : 10.1001/jama.2010.1923
Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study, BMJ, vol.339, issue.nov10 2, p.4460, 2009. ,
DOI : 10.1136/bmj.b4460
URL : https://hal.archives-ouvertes.fr/inserm-01165000
Trajectories of Gait Speed Predict Mortality in Well-Functioning Older Adults: The Health, Aging and Body Composition Study, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.68, issue.4, pp.456-464, 2013. ,
DOI : 10.1093/gerona/gls197
Gait Speed as a Measure in Geriatric Assessment in Clinical Settings: A Systematic Review, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.68, issue.1, pp.39-46, 2013. ,
DOI : 10.1093/gerona/gls174
Hypertension and lower walking speed in the elderly: the Three-City study, Journal of Hypertension, vol.28, issue.7, pp.1506-1514, 2010. ,
DOI : 10.1097/HJH.0b013e328338bbec
URL : https://hal.archives-ouvertes.fr/inserm-01165024
Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy???Results from the Baltimore Longitudinal Study of Aging, Gait & Posture, vol.34, issue.4, pp.548-552, 2011. ,
DOI : 10.1016/j.gaitpost.2011.07.014
Inflammatory Markers and Gait Speed Decline in Older Adults, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.66, issue.10, pp.1083-1089, 2011. ,
DOI : 10.1093/gerona/glr099
High-Density Lipoprotein Cholesterol and Objective Measures of Lower Extremity Performance in Older Nondisabled Persons: The InChianti Study, Journal of the American Geriatrics Society, vol.556, issue.(S, pp.621-629, 2008. ,
DOI : 10.1111/j.1532-5415.2007.01608.x
Interaction of HDL cholesterol concentrations on the relationship between physical function and inflammation in community-dwelling older persons, Age and Ageing, vol.39, issue.1, pp.74-80, 2010. ,
DOI : 10.1093/ageing/afp194
Statins and inflammation: an update, Current Opinion in Cardiology, vol.25, issue.4, pp.399-405, 2010. ,
DOI : 10.1097/HCO.0b013e3283398e53
Targeting inflammation to slow or delay functional decline: where are we?, Biogerontology, vol.16, issue.8, pp.603-614, 2010. ,
DOI : 10.1007/s10522-010-9289-0
Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis, JAMA, vol.297, issue.5, pp.499-508, 2007. ,
DOI : 10.1001/jama.297.5.499
HDL-cholesterol and physical performance: results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study), Age and Ageing, vol.36, issue.5, pp.514-520, 2007. ,
DOI : 10.1093/ageing/afm105
Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.59, issue.3, pp.242-248, 2004. ,
DOI : 10.1093/gerona/59.3.M242
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits, Circulation, vol.103, issue.7, pp.993-999, 2001. ,
DOI : 10.1161/01.CIR.103.7.993
White matter lesions volume and motor performances in the elderly, Annals of Neurology, vol.51, issue.6, pp.706-715, 2009. ,
DOI : 10.1002/ana.21674
Brain White Matter Hyperintensities: Relative Importance of Vascular Risk Factors in Nondemented Elderly People, Radiology, vol.237, issue.1, pp.251-257, 2005. ,
DOI : 10.1148/radiol.2371041496
Effects of statins on the progression of cerebral white matter lesion, Journal of Neurology, vol.83, issue.7, pp.750-757, 2009. ,
DOI : 10.1007/s00415-009-5008-7
Statins: Mechanisms of neuroprotection, Progress in Neurobiology, vol.88, issue.1, pp.64-75, 2009. ,
DOI : 10.1016/j.pneurobio.2009.02.002
Pretreatment with lovastatin prevents Nmethyl-D-aspartate-induced neurodegeneration in the magnocellular nucleus basalis and behavioral dysfunction, J Alzheimers Dis, vol.17, pp.327-336, 2009. ,
Inflammatory Markers and Physical Performance Among Nonagenarians, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.65, issue.6, pp.658-663, 2010. ,
DOI : 10.1093/gerona/glq056
Statin therapy and angiogenesis, Current Opinion in Lipidology, vol.14, issue.6, pp.599-603, 2003. ,
DOI : 10.1097/00041433-200312000-00008
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003, British Journal of Clinical Pharmacology, vol.20, issue.9, pp.543-551, 2005. ,
DOI : 10.1016/S0140-6736(00)04209-4
Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines, Annals of Pharmacotherapy, vol.110, issue.9, pp.1208-1215, 2008. ,
DOI : 10.1345/aph.1L181
Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect, American Journal of Epidemiology, vol.166, issue.3, pp.348-354, 2007. ,
DOI : 10.1093/aje/kwm070
Preventing Alzheimer's disease and cognitive decline, Evid Rep Technol Assess, vol.193, p.297, 2010. ,
Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients, JAMA, vol.291, issue.15, pp.1864-1870, 2004. ,
DOI : 10.1001/jama.291.15.1864
Persistent x Time 0.51 (0.21 to 0.81) <0 ,